What are the Challenges in Preclinical Nanotechnology Studies?
Some of the key challenges include:
- Standardization: Establishing standardized protocols for testing and evaluating nanomaterials. - Regulatory hurdles: Navigating the regulatory landscape, which may not be fully adapted to nanotechnology. - Toxicity assessment: Accurately predicting the long-term effects and potential toxicity of nanoparticles. - Complexity: Understanding the multifaceted interactions at the nanoscale level.
